National Jewish Health faculty earn 3 awards from the American Thoracic Society

May 11, 2016

Three members of the National Jewish Health faculty will be honored for contributions to pulmonary medicine this week at the American Thoracic Society (ATS) International Conference in San Francisco.

Charles Daley, MD, chief of the Division of Respiratory and Mycobacterial Infections at National Jewish Health, will receive the 2016 World Lung Health Award for his efforts around the world to improve diagnosis and treatment of patients with tuberculosis, the world's most deadly infectious disease. For more than two decades, Dr. Daley has worked with physicians, hospitals, health ministers and others to stop the spread of tuberculosis in countries around the world, from Russia to China, India to South Africa. He currently holds leadership positions in the World Health Organization and the Stop TB Partnership. A significant focus of his current efforts is improving patient access to second-line antibiotics for drug-resistant tuberculosis.

Irina Petrache, MD, chief of the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health, will receive the 2016 Elizabeth A. Rich, MD, Award given each year to a woman who has made significant achievements in pulmonary medicine, demonstrated leadership and shown dedication to mentoring. Before leading one of the largest pulmonary divisions in the nation at National Jewish Health, Dr. Petrache was Vice Chair of Research at Indiana University. She also chaired the ATS International Conference for three years. At this year's conference, she will speak at a seminar on successfully competing for an academic job, chair a 'Mythbusters' symposium and co-author eight scientific posters.

James Crapo, MD, professor of medicine at National Jewish Health, will receive the ATS Assembly on Clinical Problems 2016 Sreedhar Nair Lifetime Achievement Award in COPD. Dr. Crapo chaired the Department of Medicine at National Jewish Health from 1996 to 2004. Since 2007, he has been co-principal investigator of COPDGene, an NHLBI funded multi-center study of 10,500 smokers, former smokers and control subjects to discover genetic factors that contribute to the development of COPD and develop new therapeutic approaches to control the third leading cause of death in the world. At the conference this year, COPDGene investigators are presenting 33 scientific abstracts, ranging from genetic risk factors to plasma biomarkers to identify COPD subtypes, to gender and hormonal differences in COPD.
National Jewish Health is the leading respiratory hospital in the nation. Founded in 1899 as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit

National Jewish Health

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to